ClinicalTrials.gov
public full text
Public Domain
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
The aim of this study is to determine the usefulness of circulating tumor DNA as a prognostic factor in patients with pancreatic cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Blood Markers of Early Pancreas Cancer#300428
- Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer#898116
- Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients#870355
- Analysis of Circulating Tumor Markers in Blood#127608
- Feasibility of a New Technology for Isolating Circulating Tumour Cells#884624
Record · ID 800387
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive